SBP-GSK Center for Translational Neuroscience to study brain disorders

LA JOLLA, Calif. — GlaxoSmithKline is teaming up with the Sanford Burnham Prebys Medical Discovery Institute to study brain function and ways to potentially reverse or slow down neurodegeneration.

The London-based pharmaceutical company, which has operations in Philadelphia and Montgomery County, and the independent nonprofit medical research organization has created the SBP-GSK Center for Translational Neuroscience to identify and validate new targets for treating neurological disorders.

The center will be based at the institute’s campus in La Jolla, Calif.

Read more

Source: Philadelphia Business Journal

Shared By